Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Precision BioSciences Inc    DTIL

PRECISION BIOSCIENCES INC

(DTIL)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Precision BioSciences: 2Q Earnings Snapshot

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2019 | 04:50pm EDT

DURHAM, N.C. (AP) _ Precision BioSciences Inc. (DTIL) on Wednesday reported a loss of $19.4 million in its second quarter.

The Durham, North Carolina-based company said it had a loss of 39 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.

The genome editing company posted revenue of $5.4 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $8.2 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DTIL at https://www.zacks.com/ap/DTIL

Automated Insights, source Associated Press News

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PRECISION BIOSCIENCES INC
08/14PRECISION BIOSCIENCES : 2Q Earnings Snapshot
AQ
08/14PRECISION BIOSCIENCES INC : Results of Operations and Financial Condition, Finan..
AQ
08/14PRECISION BIOSCIENCES : Management's Discussion and Analysis of Financial Condit..
AQ
08/14Precision BioSciences Reports Second Quarter 2019 Financial Results and Highl..
GL
07/18Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedica..
GL
07/10Elo Life Systems' Mario G. Pennisi Awarded BIO Leadership and Legacy Award in..
GL
06/13PRECISION BIOSCIENCES : Appoints Dario Scimeca as General Counsel
AQ
06/12Precision BioSciences Appoints Dario Scimeca as General Counsel
GL
06/07PRECISION BIOSCIENCES INC : Regulation FD Disclosure, Financial Statements and E..
AQ
05/29Precision BioSciences to Present at Upcoming Investor Conferences
GL
More news
Financials (USD)
Sales 2019 27,1 M
EBIT 2019 -102 M
Net income 2019 -121 M
Finance 2019 175 M
Yield 2019 -
P/E ratio 2019 -3,22x
P/E ratio 2020 -3,66x
EV / Sales2019 11,0x
EV / Sales2020 10,7x
Capitalization 474 M
Chart PRECISION BIOSCIENCES INC
Duration : Period :
Precision BioSciences Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PRECISION BIOSCIENCES INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 23,17  $
Last Close Price 9,37  $
Spread / Highest target 156%
Spread / Average Target 147%
Spread / Lowest Target 124%
EPS Revisions
Managers
NameTitle
Shalini Sharp Director
Sector and Competitors
1st jan.Capitalization (M$)
PRECISION BIOSCIENCES INC0.00%447
IQVIA HOLDINGS INC33.61%29 805
LONZA GROUP34.43%25 750
INCYTE CORPORATION30.71%17 337
CELLTRION, INC.--.--%16 155
EXACT SCIENCES CORPORATION87.35%15 308